MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$483,062
Unit: Dollar
Positive Cash Flow Breakdown
    • Accounts payable and accrued exp...
    • Accrued compensation
    • Prepaid expenses and other asset...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accounts receivable
    • Operating lease liabilities
Cash Flow
2025-09-30
2025-06-30
Net loss
-1,156,208
-2,877,154
Stock-based compensation expense
105,056
188,637
Non-cash interest expense
126,028
247,945
Non-cash operating lease expense
19,146
38,294
Accounts receivable
285,043
485,070
Prepaid expenses and other assets
-154,688
-571,766
Inventories
-41,964
196,791
Accounts payable and accrued expenses
328,005
1,247,099
Accrued compensation
163,776
-258,511
Operating lease liabilities
-19,370
-38,742
Net cash used in operating activities
-521,958
-1,562,527
Proceeds from the issuance of common stock pursuant to the espp
38,896
24,999
Net cash provided by financing activities
38,896
24,999
Net (decrease) increase in cash and cash equivalents
-483,062
-1,537,528
Cash and cash equivalents at beginning of period
13,596,600
-
Cash and cash equivalents at end of period
11,576,010
-
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from theissuance of common stock...$38,896 Net cash provided byfinancing activities$38,896 Net (decrease)increase in cash and cash...-$483,062 Canceled cashflow$38,896 Accounts payable andaccrued expenses$328,005 Accrued compensation$163,776 Prepaid expenses andother assets-$154,688 Non-cash interestexpense$126,028 Stock-based compensationexpense$105,056 Inventories-$41,964 Non-cash operating leaseexpense$19,146 Net cash used inoperating activities-$521,958 Canceled cashflow$938,663 Net loss-$1,156,208 Accounts receivable$285,043 Operating leaseliabilities-$19,370

Evoke Pharma Inc (EVOK)

Evoke Pharma Inc (EVOK)